期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY LetPub Score 7.5
50 ratings
Rate
Reputation 8.7 Influence 6.7 Speed 6.9 | ||||||||||||||||||||||||
期刊簡稱 | CRIT REV ONCOL HEMAT | ||||||||||||||||||||||||
ISSN | 1040-8428 | ||||||||||||||||||||||||
E-ISSN | 1879-0461 | ||||||||||||||||||||||||
h-index | 111 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 1.80%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.croh-online.com/ | ||||||||||||||||||||||||
在線稿件提交 | http://ees.elsevier.com/croh | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 1983 | ||||||||||||||||||||||||
每年文章數 | 181每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 22.05% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 27.3 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary 來自Elsevier的數據: 83% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 8.8 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY] 的評論 | 撰寫評論 |
作者: 碧水傲文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-28 10:41:04 評論於 How did you find the email address of the editor-in-chief?(0) 讚! | 碧水傲文 |
作者: 无妄迎真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-25 13:17:22 評論於 Is there any news now?(0) 讚! | 无妄迎真 |
作者: 百花梦竹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-29 14:11:11 評論於 Focused research direction: tumor experience sharing: Submitted on December 15th, still with editor(0) 讚! | 百花梦竹 |
作者: MW小白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-23 12:48:05 評論於 Submitted on 21st November 2023, still "with editor" as of 23rd January 2024. No response received from editor after sending withdrawal email. It is recommended not to submit to this journal(0) 讚! | MW小白 |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-17 23:44:38 評論於 Review speed: 3.0 Research focus: Review articles Experience sharing in hematologic tumors: with editor My submission has been in the "with editor" status for two and a half months, and then it was rejected directly, wasting three months of my time. Please be cautious when submitting(0) 讚! | 韦陀丽萍 |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-12 18:43:37 評論於 I have reminded three times already(0) 讚! | 韦陀丽萍 |
作者: 南川怀南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-02 14:38:24 評論於 Is there any news now? I would like to have a reference(0) 讚! | 南川怀南 |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 16:24:03 評論於 Heavy research direction: Overview; Blood cancer experience sharing: with editor for one month, two reminders, still no news, frustrating(0) 讚! | 韦陀丽萍 |
作者: 南川怀南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-12 19:38:23 評論於 Is there any follow-up to this? I would like to reference it, thank you(0) 讚! | 南川怀南 |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-10 13:46:01 評論於 On the second day(0) 讚! | 法慧若曦 |
作者: 韦陀丽萍 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-06 17:30:11 評論於 It's been almost half a month and I'm still with the editor. How long did it take for you to receive a response after emailing them?(0) 讚! | 韦陀丽萍 |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-16 15:05:47 評論於 Do I need to pay for layout fee?(0) 讚! | 法慧若曦 |
作者: Humphrey Senior 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-13 15:35:32 評論於 Hello, how long have you been waiting?(0) 讚! | Humphrey Senior |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-10 21:53:11 評論於 Review speed: 12.0 | Submission acceptance rate: 50.0 Research focus: Blood; Tumor; Review sharing experience Submitted on 26th May 2023, with editor after 3 days. Still with editor after half a month, so I sent an email to follow up. Under review on 18th June 2023, but no response after two months. Followed up with the journal again, no response. Frustrated, I contacted the editor, and surprisingly received minor revisions on 22nd August. Sent back for revisions on 28th August, still with editor. After half a month, still with editor. Couldn't wait any longer, contacted the editor, no response, followed up with the editor again. Finally accepted on 12th September 2023. In conclusion, this journal only accepts reviews, and the entire process is very slow, with irresponsible editors. Consider carefully before submitting(0) 讚! | 法慧若曦 |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-31 15:27:54 評論於 How long have you been waiting, big boss?(0) 讚! | 法慧若曦 |
作者: 水月勇毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-17 23:34:45 評論於 Review speed: 1.0 | Submission success rate: 25.0 Focus on research areas:Pharmacology Experience sharing: The editor took a month to reject the submission. This journal's editors are really something, I submitted on July 13th, inquired about the status via email 3 times with no response each time. Later, I emailed the editor-in-chief and the submission was rejected the next day(0) 讚! | 水月勇毅 |
作者: 长平baby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 11:47:41 評論於 Does his home only accept summaries? Can't research papers be submitted?(0) 讚! | 长平baby |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-03 22:32:12 評論於 Under review for nearly a month, no changes yet. Probably unable to find a reviewer again(0) 讚! | 法慧若曦 |
作者: 落英巧易 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-03 15:45:21 評論於 Research Focus: Tumors; Sharing Experience on Gastric Cancer: Submitted a network meta-analysis on July 1st, 7.2 with editor, continuously updating(0) 讚! | 落英巧易 |
作者: 削月冰蓝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-28 18:54:48 評論於 Hello, how are you doing?(0) 讚! | 削月冰蓝 |
作者: 法慧若曦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-05 22:45:24 評論於 It has been ten days with the editor, how much longer do we have to wait?(0) 讚! | 法慧若曦 |
作者: 回风念南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-18 22:46:19 評論於 The submission has been rejected(0) 讚! | 回风念南 |
作者: 回风念南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-11 09:39:43 評論於 Research focus: review Experience sharing: A few days after submission, it changed from "With editor" to "Decision in process"(0) 讚! | 回风念南 |
作者: 回风念南 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-10 18:52:08 評論於 How long does it take for the editor to review?(0) 讚! | 回风念南 |
作者: 天池可馨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-08 16:31:53 評論於 By the end of 2021(0) 讚! | 天池可馨 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us